FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Valeria Visconte

Research Profile

Disorders

Physiology

Chemicals & Drugs

Living Beings

Mouse

Anatomy

Bone Marrow Cells

Procedures

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Concepts & Ideas

Mutation Rate

Co-author Network

Publications

TOP 3
Reda Z Mahfouz; Tomas Radivoyevitch; Mikkael A Sekeres; Ali Tabarroki; Pramod Terse; Ramon Tiu; Valeria Visconte; Kenneth Chan; Joseph Covey; Quteba Ebrahem; Kory J Engelke; Xiaorong Gu; Ania Jankowska; Yonghua Ling; Jaroslaw Maciejewski; Yogen Saunthararajah
Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy.
Sarah Abu Kar; Seiji Kojima; Alan F List; Manuel Afable; Kathryn Guinta; Anna Jankowska; Andres Jerez; Hideki Makishima; Michael A McDevitt; Hideki Muramatsu; Bartlomiej Przychodzen; Hirotoshi Sakaguchi; Mikkael A Sekeres; Yuka Sugimoto; Ramon Tiu; Fabiola Traina; Valeria Visconte; Jaroslaw P Maciejewski
Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia.
Mikkael A Sekeres; Ali Tabarroki; Ramon Tiu; Valeria Visconte; Hideki Makishima; Jennifer Paleveda; Ronald Paquette; Anjali S Advani; Manuel Afable; David Cuthbertson; Ricki Englehaupt; Andres Jerez; Joyce Juersivich; Rami S Komrokji; Jeffrey E Lancet; Alan F List; Jaroslaw P Maciejewski
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Valeria Visconte (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Reda Z Mahfouz; Tomas Radivoyevitch; Mikkael A Sekeres; Ali Tabarroki; Pramod Terse; Ramon Tiu; Valeria Visconte; Kenneth Chan; Joseph Covey; Quteba Ebrahem; Kory J Engelke; Xiaorong Gu; Ania Jankowska; Yonghua Ling; Jaroslaw Maciejewski; Yogen Saunthararajah
Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(4):938-48.
2013: Sarah Abu Kar; Seiji Kojima; Alan F List; Manuel Afable; Kathryn Guinta; Anna Jankowska; Andres Jerez; Hideki Makishima; Michael A McDevitt; Hideki Muramatsu; Bartlomiej Przychodzen; Hirotoshi Sakaguchi; Mikkael A Sekeres; Yuka Sugimoto; Ramon Tiu; Fabiola Traina; Valeria Visconte; Jaroslaw P Maciejewski
Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia.
Haematologica 2013;98(1):107-13.
2012: Mikkael A Sekeres; Ali Tabarroki; Ramon Tiu; Valeria Visconte; Hideki Makishima; Jennifer Paleveda; Ronald Paquette; Anjali S Advani; Manuel Afable; David Cuthbertson; Ricki Englehaupt; Andres Jerez; Joyce Juersivich; Rami S Komrokji; Jeffrey E Lancet; Alan F List; Jaroslaw P Maciejewski
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.
Blood 2012;120(25):4945-51.
2012: Hirotoshi Sakaguchi; Ramon Tiu; Valeria Visconte; Anna M Jankowska; Andres Jerez; Jaroslaw P Maciejewski; Hideki Makishima; Hideki Muramatsu; Seiji Kojima
Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies.
Leukemia research 2012;36(12):e215-7.
2012: Valeria Visconte; Jaroslaw P Maciejewski; Hideki Makishima; Ramon Tiu
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders.
Leukemia 2012;26(12):2447-54.
2012: Valeria Visconte; Fabiola Traina; Anjali Advani; John Barnard; Manoj Bupathi; Edward Copelan; Kyoichi Isono; Anna Jankowska; Andres Jerez; Kazunori Koide; Haruhiko Koseki; Jaroslaw P Maciejewski; Hideki Makishima; James McMahon; Christine L O'Keefe; Sami Osman; Richard A Padgett; Heesun J Rogers; Yogen Saunthararajah; Mikkael A Sekeres; Jarnail Singh; Hadrian Szpurka; Ramon Tiu
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.
Blood 2012;120(16):3173-86.
2012: Andres Jerez; Seiji Kojima; Austin G Kulasekararaj; Alan List; Jacqueline Boultwood; Anna Jankowska; Hideki Makishima; A MICHAEL MCDEVITT; Kathy McGraw; Azim Mohamedali; Alison R Moliterno; Ghulam J Mufti; Hideki Muramatsu; Christine L O'Keefe; Andrea Pellagatti; Bartlomiej Przychodzen; Mikkael A Sekeres; Yuka Sugimoto; Ramon Tiu; Amit Verma; Valeria Visconte; Jaroslaw P Maciejewski
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.
Blood 2012;119(25):6109-17.
2012: Hideki Makishima; Richard A Padgett; Bartlomiej Przychodzen; Hirotoshi Sakaguchi; Mikkael A Sekeres; Ramon Tiu; Valeria Visconte; Sarah Abu Kar; Manuel G Afable; Manoj Bupathi; Kathryn Guinta; Anna Jankowska; Andres Jerez; Jaroslaw P Maciejewski
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.
Blood 2012;119(14):3203-10.
2012: Valeria Visconte; F Traina; Anna Jankowska; A Jerez; Jaroslaw P Maciejewski; Hideki Makishima; Christine L O'Keefe; H J Rogers; Mikkael A Sekeres; Hadrian Szpurka; Ramon Tiu
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts.
Leukemia 2012;26(3):542-5.
2012: Fabiola Traina; Valeria Visconte; Anjali S Advani; Edward Copelan; Hien K Duong; Paul Elson; Yingchun Han; Fred H Hsieh; Anna Jankowska; Matt Kalaycio; Reuben Kapur; Alan E Lichtin; Jaroslaw P Maciejewski; Hideki Makishima; Raghuveer Singh Mali; Christine L O'Keefe; Sara T Olalla Saad; Mikkael A Sekeres; Ramon Tiu
Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.
PloS one 2012;7(8):e43090.
2012: Yuka Sugimoto; Hadrian Szpurka; Ramon Tiu; Fabiola Traina; Valeria Visconte; Manuel Afable; Kathryn Guinta; Anna Jankowska; Andres Jerez; Alan F List; Hideki Makishima; Kathy L McGraw; Christine L O'Keefe; Mikkael A Sekeres; Jaroslaw Maciejewski
Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.
Journal of hematology & oncology 2012;5():4.
2011: Anna Jankowska; Alan F List; Eric D Hsi; Yun Huang; Hideki Makishima; A MICHAEL MCDEVITT; Christine L O'Keefe; Courtney Prince; Anjana Rao; Mikkael A Sekeres; Yuka Sugimoto; Hadrian Szpurka; Ramon Tiu; Fabiola Traina; Valeria Visconte; Jaroslaw P Maciejewski
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.
Blood 2011;118(14):3932-41.
2011: Raghuveer Singh Mali; Veerendra Munugalavadla; Sarah C Nabinger; Baskar Ramdas; Jianjian Shi; Emily Sims; Andrew M Stern; Ramon V Tiu; Fabiola Traina; Sasidhar Vemula; Valeria Visconte; Lei Wei; Qiang Wen; H Scott Boswell; Rebecca J Chan; John D Crispino; Charles B Goodwin; Timothy A Lewis; Peilin Ma; Reuben Kapur
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL.
Cancer cell 2011;20(3):357-69.
2011: Nunzia Montuori; Ada Pesapane; Daniela Alfano; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Francesca Wanda Rossi; Guido Rossi; Salvatore Salzano; Valeria Visconte; Pia Ragno
The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.
Cellular and molecular life sciences : CMLS 2011;68(14):2453-67.
2011: Ramon Tiu; Valeria Visconte; Fabiola Traina; Anita Schwandt; Jaroslaw P Maciejewski
Updates in cytogenetics and molecular markers in MDS.
Current hematologic malignancy reports 2011;6(2):126-35.
2011: Elaine M Sloand; J Joseph Melenhorst; Zachary C G Tucker; Loretta Pfannes; Jason M Brenchley; Agnes S M Yong; Valeria Visconte; Colin Wu; Emma Gostick; Phillip Scheinberg; Matthew J Olnes; Daniel C Douek; David A Price; A John Barrett; Neal S Young
T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy.
Blood 2011;117(9):2691-9.
2010: Regis Peffault de Latour; Valeria Visconte; Tomoiku Takaku; Colin Wu; Andrew J Erie; Annahita K Sarcon; Marie J Desierto; Phillip Scheinberg; Keyvan Keyvanfar; Olga Nunez; Jichun Chen; Neal S Young
Th17 immune responses contribute to the pathophysiology of aplastic anemia.
Blood 2010;116(20):4175-84.
2010: Valeria Visconte; Nalini Raghavachari; Delong Liu; Keyvan Keyvanfar; Marie J Desierto; Jichun Chen; Neal S Young
Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells.
Haematologica 2010;95(2):214-23.
2009: Annahita K Sarcon; Marie J Desierto; Wenjun Zhou; Valeria Visconte; Federica Gibellini; Jichun Chen; Neal S Young
Role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure.
Experimental hematology 2009;37(4):477-86.
2007: Elena E Solomou; Katayoun Rezvani; Stephan Mielke; Daniela Malide; Keyvan Keyvanfar; Valeria Visconte; Sachiko Kajigaya; A John Barrett; Neal S Young
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia.
Blood 2007;110(5):1603-6.
2007: Elena E Solomou; Susan Wong; Valeria Visconte; Federica Gibellini; Neal S Young
Decreased TCR zeta-chain expression in T cells from patients with acquired aplastic anaemia.
British journal of haematology 2007;138(1):72-6.
2007: Elena E Solomou; Federica Gibellini; Brian Stewart; Daniela Malide; Maria Berg; Valeria Visconte; Spencer Green; Richard Childs; STEPHEN CHANOCK; Neal S Young
Perforin gene mutations in patients with acquired aplastic anemia.
Blood 2007;109(12):5234-7.
2006: Carmine Selleri; Nunzia Montuori; Patrizia Ricci; Valeria Visconte; Antonio Baiano; Maria Vincenza Carriero; Bruno Rotoli; Guido Rossi; Pia Ragno
In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.
Cancer research 2006;66(22):10885-90.
2006: Carmine Selleri; Pia Ragno; Patrizia Ricci; Valeria Visconte; Nicola Scarpato; Maria Vincenza Carriero; Bruno Rotoli; Guido Rossi; Nunzia Montuori
The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization.
Blood 2006;108(7):2476-84.
2005: Carmine Selleri; Nunzia Montuori; Patrizia Ricci; Valeria Visconte; Maria Vincenza Carriero; Nicolai Sidenius; Bianca Serio; Francesco Blasi; Bruno Rotoli; Guido Rossi; Pia Ragno
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization.
Blood 2005;105(5):2198-205.
2005: Nunzia Montuori; Valeria Visconte; Guido Rossi; Pia Ragno
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?
Thrombosis and haemostasis 2005;93(2):192-8.
2004: amato de paulis; Nunzia Montuori; Nella Prevete; Isabella Fiorentino; Francesca Wanda Rossi; Valeria Visconte; Guido Rossi; Gianni Marone; Pia Ragno
Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(9):5739-48.
2003: Carmine Selleri; Jaroslaw P Maciejewski; Nunzia Montuori; Patrizia Ricci; Valeria Visconte; Bianca Serio; Luigiana Luciano; Bruno Rotoli
Involvement of nitric oxide in farnesyltransferase inhibitor-mediated apoptosis in chronic myeloid leukemia cells.
Blood 2003;102(4):1490-8.